VistaGen Therapeutics
VTGN
VTGN
33 hedge funds and large institutions have $1.82M invested in VistaGen Therapeutics in 2023 Q2 according to their latest regulatory filings, with 4 funds opening new positions, 11 increasing their positions, 16 reducing their positions, and 54 closing their positions.
New
Increased
Maintained
Reduced
Closed
more ownership
Funds ownership: →
less repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
93% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 54
Holders
33
Holding in Top 10
–
Calls
$31K
Puts
–
Top Buyers
| 1 | +$292K | |
| 2 | +$189K | |
| 3 | +$111K | |
| 4 |
Goldman Sachs
New York
|
+$101K |
| 5 |
YIH
Y-Intercept (HK)
Hong Kong
|
+$89.2K |
Top Sellers
| 1 | -$627K | |
| 2 | -$353K | |
| 3 | -$108K | |
| 4 |
Northern Trust
Chicago,
Illinois
|
-$95.4K |
| 5 |
MCM
MAI Capital Management
Independence,
Ohio
|
-$72.9K |